Animal models for an integrated approach to the pharmacologic control of atherosclerosis.
A system of animal models potentially useful for the discovery and evaluation of new effective antiatherosclerotic agents is described. The models consist of a series of lipoprotein and atherosclerosis assays in rats, SEA Japanese quail and cynomolgus monkeys. SEA quail are particularly useful for detecting compounds that inhibit arterial cholesterol deposition. The use of this integrated system of models is illustrated with data on clofibrate, adamantyloxyaniline (a hypobetalipoproteinemic agent), and o,p'-DDD. Male SEA quail appear to be a quite satisfactory model for testing the effects of large numbers of compounds on atherosclerosis and are available in limited numbers to all qualified investigators in the field of atherosclerosis research for evaluation in their laboratories.
D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D002994:Clofibrate / Q000627:therapeutic use; D003370:Coturnix; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D005260:Female; D000882:Haplorhini; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008252:Macaca fascicularis; D008297:Male; D008939:Mitotane / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D051381:Rats; D009626:Terminology as Topic
D000814:Aniline Compounds; D000960:Hypolipidemic Agents; D010880:Piperidines; D008939:Mitotane; D002994:Clofibrate; D000218:Adamantane